Morningstar Investor users sign in here.
We’re currently having some problems with our data feed. We apologise for any inconvenience.

Company Profile

  • Business description

    Abliva AB is a Swedish company that is active in pharmaceutical development. It develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare, and often very severe diseases occur when the cell's energy provider, the mitochondria, does not function properly. The portfolio includes projects at different stages and ranges from the early discovery phase to the clinical phase. . The company is focused on two projects. KL1333, a powerful NAD+ and NADH regulator, in late-stage development and has been granted orphan drug designation in Europe and the US. NV354, an energy replacement therapy, has just completed preclinical development.

  • Contact

    Scheeletorget 1
    Medicon Village
    Lund 223 81
    SWE

    T: +46 462756220

    https://www.abliva.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    6

Stocks News & Analysis

stocks

A 15 step checklist from Buffett's forgotten inspiration

Phil Fisher achieved remarkable stock market returns by holding high quality growth companies for long periods of time. Here's how he found them.
video

Are Guzman's growth targets realistic?

Morningstar Equity Analyst Lochlan Halloway discusses Guzman's upcoming IPO. 
stocks

Apple: Generative AI strategy should drive sales and upgrades

We were pleased with the newly announced Apple Intelligence suite of features.

Markets

Index
Last price
Change
% Change
All Ordinaries 7,974.80 27.70 -0.35%
CAC 40 7,503.27 204.75 -2.66%
DAX 40 18,002.02 263.66 -1.44%
Dow JONES (US) 38,589.16 57.94 -0.15%
FTSE 100 8,146.86 16.81 -0.21%
HKSE 17,941.78 170.85 -0.94%
NASDAQ 17,688.88 21.32 0.12%
Nikkei 225 38,814.56 94.09 0.24%
NZX 50 Index 11,864.89 7.75 -0.07%
S&P 500 5,431.60 2.14 -0.04%
S&P/ASX 200 7,724.30 25.40 -0.33%
SSE Composite Index 3,032.63 3.71 0.12%

Market Movers

Name
Last price
Change
% Change
Pilbara Minerals Ltd PLS 3.24 0.08 -2.41%
Peninsula Energy Ltd PEN 0.11 0.01 5.00%
Sayona Mining Ltd SYA 0.04 0.00 -2.70%
Zip Co Ltd ZIP 1.45 0.14 10.27%
Orora Ltd ORA 1.96 0.10 -4.63%
South32 Ltd S32 3.66 0.02 0.55%
Tabcorp Holdings Ltd TAH 0.66 0.06 10.08%
Adbri Ltd ABC 3.19 0.00 0.00%
Resolute Mining Ltd RSG 0.51 0.04 -7.27%
Core Lithium Ltd CXO 0.09 0.00 -2.13%